A share price of Cardiol Therapeutics Inc [CRDL] is currently trading at $2.07, up 7.25%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRDL shares have gain 15.00% over the last week, with a monthly amount glided 13.11%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cardiol Therapeutics Inc [NASDAQ: CRDL] stock has seen the most recent analyst activity on June 26, 2024, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $10. Previously, H.C. Wainwright started tracking the stock with Buy rating on April 22, 2024, and set its price target to $9.
Cardiol Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.72 and $3.12. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Cardiol Therapeutics Inc [NASDAQ: CRDL] shares were valued at $2.07 at the most recent close of the market. An investor can expect a potential return of 286.47% based on the average CRDL price forecast.
Analyzing the CRDL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.11, Equity is -1.19 and Total Capital is -2.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.9000 points at the first support level, and at 1.7300 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.2400, and for the 2nd resistance point, it is at 2.4100.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cardiol Therapeutics Inc [NASDAQ:CRDL] is 2.39. Also, the Quick Ratio is 2.39, while the Cash Ratio stands at 2.22.
